Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
Authors
Keywords
-
Journal
EUROPACE
Volume 18, Issue 7, Pages 955-964
Publisher
Oxford University Press (OUP)
Online
2015-03-29
DOI
10.1093/europace/euv030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Bleeding With Dabigatran in Atrial Fibrillation
- (2015) Inmaculada Hernandez et al. JAMA Internal Medicine
- Late-Breaking Clinical Trial Abstracts
- (2014) CIRCULATION
- Which drug should we use for stroke prevention in atrial fibrillation?
- (2014) Yee C. Lau et al. CURRENT OPINION IN CARDIOLOGY
- Comparison of the efficacy of periprocedural rosuvastatin versus atorvastatin treatment in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
- (2014) T. Q. Zhu et al. EUROPEAN HEART JOURNAL
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
- (2014) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reversal of Coagulopathy Using Prothrombin Complex Concentrates is Associated with Improved Outcome Compared to Fresh Frozen Plasma in Warfarin-Associated Intracranial Hemorrhage
- (2014) Jennifer A. Frontera et al. Neurocritical Care
- Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
- (2014) Jack E. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
- (2014) Raffaele de Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
- (2014) Takeshi Fuji et al. THROMBOSIS RESEARCH
- Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
- (2014) Elisabeth Perzborn et al. THROMBOSIS RESEARCH
- Potential antidotes for reversal of old and new oral anticoagulants
- (2014) Deepa Suryanarayan et al. THROMBOSIS RESEARCH
- Safety and efficacy of edoxaban in patients undergoing hip fracture surgery
- (2014) Takeshi Fuji et al. THROMBOSIS RESEARCH
- Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects
- (2013) Xiaoli Wang et al. American Journal of Cardiovascular Drugs
- A specific antidote for dabigatran: functional and structural characterization
- (2013) F. Schiele et al. BLOOD
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis
- (2013) Anne-Céline Martin et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
- (2013) Genmin Lu et al. NATURE MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran and Postmarketing Reports of Bleeding
- (2013) Mary Ross Southworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood
- (2013) Gines Escolar et al. PLoS One
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban
- (2013) Wei Zhou et al. STROKE
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- (2013) Steen Husted et al. THROMBOSIS AND HAEMOSTASIS
- Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates
- (2013) András Gruber et al. THROMBOSIS AND HAEMOSTASIS
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
- (2012) Francesco Dentali et al. CIRCULATION
- Reversal of Warfarin
- (2012) David A. Garcia et al. CIRCULATION
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
- (2012) Robert G. Hart et al. STROKE
- Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal
- (2012) Dar Dowlatshahi et al. STROKE
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
- (2012) Raphael Marlu et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor
- (2012) A. G. G. Turpie et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Measuring the anticoagulant effect of direct factor Xa inhibitors. Is the anti-Xa assay preferable to the prothrombin time test?
- (2011) Armando Tripodi THROMBOSIS AND HAEMOSTASIS
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
- (2011) Chiara Marchesi et al. THROMBOSIS AND HAEMOSTASIS
- Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects
- (2010) B. E. Skolnick et al. BLOOD
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- The clinical impact of bleeding during oral anticoagulant therapy
- (2010) Minna Guerrouij et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
- (2010) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
- (2010) Zhaoqing Wang et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study
- (2010) R. Demeyere et al. VOX SANGUINIS
- Editorial Board
- (2009) JOURNAL OF ARTHROPLASTY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage
- (2008) Alexander Y. Zubkov et al. ARCHIVES OF NEUROLOGY
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Warfarin use leads to larger intracerebral hematomas
- (2008) M. L. Flaherty et al. NEUROLOGY
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage
- (2008) Brett Cucchiara et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now